NEOPHORE
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms, enabling cancer patients to get treated and achieve improved clinical outcomes.
NEOPHORE
Industry:
Biotechnology Simulation Therapeutics Translation Service
Founded:
2017-11-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neophore.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1223 804250
Email Addresses:
[email protected]
Total Funding:
25.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Mobile Non Scaleable Content Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Investors List
2invest
2invest investment in Series B - NeoPhore
Astellas Venture Management
Astellas Venture Management investment in Series B - NeoPhore
3B Future Health Fund
3B Future Health Fund investment in Series B - NeoPhore
Claris Ventures
Claris Ventures investment in Series B - NeoPhore
Sixth Element Capital
Sixth Element Capital investment in Series B - NeoPhore
Innovate UK
Innovate UK investment in Grant - NeoPhore
Sixth Element Capital
Sixth Element Capital investment in Venture Round - NeoPhore
Official Site Inspections
http://www.neophore.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.56 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
